search
for
 About Bioline  All Journals  Testimonials  Membership  News


Indian Journal of Medical Sciences
Medknow Publications on behalf of Indian Journal of Medical Sciences Trust
ISSN: 0019-5359 EISSN: 1998-3654
Vol. 59, Num. 4, 2005, pp. 162-163

Indian Journal of Medical Sciences, Vol. 59, No. 4, April, 2005, pp. 162-163

Letter To Editor

Eosinophilia and valvular heart disease

Narayana Hrudayalaya, 258/A Bommasandra Industrial Area, Anekal Taluk, Bangalore - 560099, India

Correspondence Address: Narayana Hrudayalaya, 258/A Bommasandra Industrial Area, Anekal Taluk, Bangalore - 560099, India. E-mail: sharat_damodar@hotmail.com

Code Number: ms05024

Sir,

The endocardial disease associated with idiopathic eosinophilia was first appreciated by Loffler[1] in 1936. Since then, numerous reports and small series of patients have firmly established the association of these findings. [2,3] Indeed, cardiovascular disease has been recognized as the major cause of morbidity and mortality in patients with idiopathic eosinophilia.[4] Idiopathic hypereosinophilic syndrome is a rare systemic disease than can cause multiple organ failure by eosinophilic infiltration. Cardiac involvement is characterized by endocardial fibrosis and overlying thrombus, leading to restrictive cardiomyopathy and valvular dysfunction. Surgical experience of patients with mitral dysfunction caused by this syndrome is limited, and valvular replacement is most often performed.[5]

Rheumatic heart disease is the commonest cause for valvular heart disease and hence most patients are empirically labeled with this diagnosis. However, routine preoperative evaluation revealed hyper eosinophilia in three patients forcing a re-consideration of their etiology.

Three patients (two males and one female) in age group (18-35 years) were evaluated for exertional dyspnoea. Echocardiography revealed MS, MR with AS. The AR in two patients and MR in one patient. The patient with only MR also had a neurological deficit. The CT Brain revealed a parietal infarct. Hyper eosinophilia was seen in all patients ranging from 2 to 22 x 1010 l-1. Bone marrow revealed eosinophilia with normal cytogenetics. Ultrasound revealed mild splenomegaly in one patient. All three had elevated IgE levels. Connective tissue and malignancy workup was negative in all three. Two patients responded to steroids whereas the third required hydroxyurea and vincristine to control the eosinophilia. Two patients underwent double valve replacement and one had MVR. The valves used for replacement were Starr-Edwards and St. Jude valves, respectively. Surgery was uneventful. The HPE revealed myxoid changes with focal aggregates of lymphocytes in two patients. One patient who had MVR with Starr-Edwards valve was readmitted 8 months later with a left ventricular clot with an intact valve. The other two patients are alive and well on follow up.

Harley et al. in an analysis of a large population of patients with the idiopathic hypereosinophilic syndrome defines two patterns of clinical illness with respect to the development of heart disease. In one pattern, heart disease was accompanied by characteristics of a primary myeloproliferative type disease.[4] In the other pattern, patients remained free of heart disease, the characteristics were more of allergic or hypersensitivity process. They tended to have elevated Ig, especially IgE, and elevated level of circulating immune complexes.[4]

In our report on three patients, one had splenomegaly, and all three had elevated IgE levels, with two patients showing a dramatic response to steroids. Abnormal eosinophil morphology or eosinophilic infiltration of valves was not demonstrable in any patient. There was no evidence of rheumatic activity on Histopathological examination of the valves or in the blood tests. In our country where Rheumatic heart disease is the most common cause for valvular heart disease other causes such as eosinophilic myocarditis needs to be actively looked for before labeling a patient. A larger number of patients would further emphasize this point.

References

1.Loffler W. Endocarditis parietalis fibroplastica, mit Blut eosinophilic ein eigenertiges Krankheits bild Schweiz. Med Wochenschr 1936;66:817-21.  Back to cited text no. 1    
2.Lin AY, Nutman TB, Kaslow D. Familial eosinophilia: Clinical and laboratory results on a US kindred. Am J Med Gen 1998;76:229-37.  Back to cited text no. 2    
3.Tang A, Karski J, Butany J, David J. Severe mitral regurgitation in eosinophilic endomyocarditis: Repair or replacement? Interactive Cardiovasc Thor Surg 2004;3:406-8.  Back to cited text no. 3    
4.Harley JB, Faucl AS, Gralnick HR. Noncardiovascular findings associated with heart disease in the idiopathic hypereosinophilic syndrome. Am J Cardiol 1983;52:321-4.  Back to cited text no. 4    
5.Fuzellier JF, Chapoutot L, Torossian PF. Mitral valve repair in idiopathic hypereosinophilic syndrome. J Heart Valve Dis 2004;13:529-31.  Back to cited text no. 5  [PUBMED]  

Copyright 2005 - Indian Journal of Medical Sciences

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil